Figures & data
Figure 1 Molecular structure of chimeric antigen receptor used for CTL019.
![Figure 1 Molecular structure of chimeric antigen receptor used for CTL019.](/cms/asset/c57b26d9-3744-4e55-a462-68fb554d8359/dtcr_a_146309_f0001_c.jpg)
Table 1 Summary of results reported from CD19 CAR T-cell pediatric clinical trials
Table 2 LD regimens used in completed pediatric trials of CD19 CAR T-cells
Figure 2 B-cell antigens used as targets for chimeric antigen receptor T cells.
![Figure 2 B-cell antigens used as targets for chimeric antigen receptor T cells.](/cms/asset/c6fd5a08-47c4-47d0-ac53-b3573ee4353b/dtcr_a_146309_f0002_c.jpg)
Table 3 Open pediatric trials using CD19 CAR T-cells (as of April 2018)